Last: | $7.30 |
---|---|
Change Percent: | -3.06% |
Open: | $7.41 |
Close: | $7.30 |
High: | $7.63 |
Low: | $7.19 |
Volume: | 2,015,291 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.3 | $7.41 | $7.3 | $7.63 | $7.19 | 2,015,291 | 05-03-2024 |
$7.19 | $7.18 | $7.19 | $7.35 | $6.81 | 2,680,810 | 05-02-2024 |
$7.07 | $6.64 | $7.07 | $7.39 | $6.55 | 4,105,411 | 05-01-2024 |
$6.55 | $6.35 | $6.55 | $6.73 | $6.31 | 3,214,672 | 04-30-2024 |
$6.395 | $6.86 | $6.395 | $6.89 | $6.282 | 4,928,316 | 04-29-2024 |
$7.26 | $7.18 | $7.26 | $7.42 | $6.9 | 2,250,760 | 04-26-2024 |
$7.2 | $6.88 | $7.2 | $7.25 | $6.78 | 2,316,111 | 04-25-2024 |
$7.08 | $7.55 | $7.08 | $7.75 | $6.98 | 2,196,097 | 04-24-2024 |
$7.57 | $7.47 | $7.57 | $8.23 | $7.47 | 3,115,633 | 04-23-2024 |
$7.47 | $7.03 | $7.47 | $7.55 | $6.85 | 2,370,062 | 04-22-2024 |
$6.91 | $6.85 | $6.91 | $7.01 | $6.64 | 3,590,526 | 04-19-2024 |
$6.89 | $6.97 | $6.89 | $7.26 | $6.85 | 3,215,984 | 04-18-2024 |
$7.04 | $7.65 | $7.04 | $7.65 | $7.01 | 3,640,921 | 04-17-2024 |
$7.52 | $7.42 | $7.52 | $7.65 | $7.23 | 2,723,827 | 04-16-2024 |
$7.55 | $7.95 | $7.55 | $7.98 | $7.32 | 3,527,172 | 04-15-2024 |
$7.99 | $8.33 | $7.99 | $8.33 | $7.75 | 3,045,846 | 04-12-2024 |
$8.4 | $8.07 | $8.4 | $8.54 | $7.9575 | 2,831,816 | 04-11-2024 |
$8.01 | $8.05 | $8.01 | $8.35 | $7.96 | 2,894,219 | 04-10-2024 |
$8.4 | $8.6 | $8.4 | $8.71 | $8.11 | 2,881,521 | 04-09-2024 |
$8.61 | $9.09 | $8.61 | $9.15 | $8.55 | 2,340,120 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
GAITHERSBURG, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update. Altimmune management w...
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present on behalf of the Company at the following two upcoming conferences: ...
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...